You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ad-ISF35

Showing 1 - 25 of 5,108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in San Diego (ISF35)

Completed
  • Chronic Lymphocytic Leukemia
  • ISF35
  • San Diego, California
    University of California, San Diego Moores Cancer Center
Sep 15, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in La Jolla (Intranodal injection of Ad-ISF35)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Intranodal injection of Ad-ISF35
  • La Jolla, California
    University of California, San Diego Moores Cancer Center
Jul 10, 2019

Atopic Dermatitis Trial in Worldwide (LEO 138559, LEO 138559 )

Completed
  • Atopic Dermatitis
  • LEO 138559
  • LEO 138559 placebo
  • Birmingham, Alabama
  • +16 more
Oct 20, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +37 more
  • Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021

HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

Completed
  • HIV Infections
  • DNA Vaccine
  • +5 more
  • Birmingham, Alabama
  • +9 more
Oct 13, 2021

Atopic Dermatitis Trial in China (CBP-201)

Not yet recruiting
  • Atopic Dermatitis
  • Beijing, Beijing, China
  • +40 more
Jun 14, 2023

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Little Rock, Arkansas
  • +54 more
Aug 2, 2022

Alzheimer, Early Onset Trial in United States (AD-35 60mg group, Placebo group)

Unknown status
  • Alzheimer Disease, Early Onset
  • AD-35 60mg group
  • Placebo group
  • Sacramento, California
  • +9 more
Mar 23, 2020

Atopic Dermatitis Trial in Worldwide (Tralokinumab, Placebos)

Completed
Has Results
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +86 more
Jul 4, 2022

Influenza, Human Trial in Worldwide (QIVc, Comparator)

Active, not recruiting
  • Influenza, Human
  • QIVc
  • Comparator
  • Dobrich, Bulgaria
  • +54 more
Jan 17, 2023

Metastatic NSCLC Trial in Worldwide (Volrustomig, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Rosario, Argentina
  • +51 more
Aug 2, 2023

Atopic Dermatitis Trial in United States (Dupilumab, Vanicream, Triamcinolone Acetonide)

Not yet recruiting
  • Atopic Dermatitis
  • Dupilumab
  • +2 more
  • La Jolla, California
  • +9 more
Jun 27, 2022

Cholinergic Integrity in Down Syndrome in Association With

Recruiting
  • Down Syndrome
  • +2 more
  • [18F]-FEOBV Radiotracer
  • Nashville, Tennessee
    Vanderbilt University Medical Center Clinical Research Center
Jan 31, 2023

Dermatitis Trial in Saint-Denis (Hypnosis)

Not yet recruiting
  • Dermatitis
  • Hypnosis
  • Saint-Denis, Réunion
    CHU de la Réunion
Jan 6, 2023

Alzheimer Trial in Kaohsiung (active tACS, sham tACS)

Not yet recruiting
  • Alzheimer Disease
  • active tACS
  • sham tACS
  • Kaohsiung, Taiwan
    Department of Psychiatry, Kaohsiung Veterans General Hospital
Feb 1, 2023

Healthy Trial in Helsinki (B. infantis, Lactose Placebo)

Recruiting
  • Healthy
  • B. infantis
  • Lactose Placebo
  • Helsinki, Finland
    HUS Children and Adolescents, Clinical Trial Unit, Park Hospital
Aug 8, 2022

Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)

Recruiting
  • Atopic Dermatitis
  • Lebrikizumab
  • Darmstadt, Hessen, Germany
  • +31 more
Jun 21, 2023

Atopic Dermatitis Trial in Worldwide (DUPILUMAB, PLACEBO)

Completed
Has Results
  • Atopic Dermatitis
  • North Little Rock, Arkansas
  • +41 more
Oct 5, 2022

Eating Rate Trial in Wageningen (ultra-processed slow eating rate diet, Ultra-processed fast eating rate diet)

Recruiting
  • Eating Rate
  • ultra-processed slow eating rate diet
  • Ultra-processed fast eating rate diet
  • Wageningen, Gelderland, Netherlands
    Wageningen University
Nov 3, 2023

Atopic Dermatitis Trial in Denver, Montreal (Dupilumab SAR231893)

Completed
Has Results
  • Atopic Dermatitis
  • Dupilumab SAR231893
  • Denver, Colorado
  • +1 more
Jul 19, 2022

Food Allergy Trial in Utrecht

Terminated
  • Food Allergy
    • Utrecht, Netherlands
      University Medical Centre Utrecht
    Jul 27, 2022

    Atopic Dermatitis Trial in Australia, New Zealand, United States (BTX 1204, Vehicle)

    Completed
    Has Results
    • Atopic Dermatitis
    • Little Rock, Arkansas
    • +30 more
    Sep 30, 2022

    Atopic Dermatitis Trial in Worldwide (DS107, Placebo)

    Terminated
    Has Results
    • Atopic Dermatitis
    • Birmingham, Alabama
    • +49 more
    Nov 3, 2022

    a High Probability of Meeting Eligibility Criteria

    Recruiting
    • Alzheimer Disease
    • +4 more
    • Prescreener database
    • San Diego, California
    • +18 more
    Dec 28, 2022

    Atopic Dermatitis Trial in France (Cholecalciferol, Placebo of cholecalciferol)

    Active, not recruiting
    • Atopic Dermatitis
    • Bordeaux, France
    • +10 more
    Aug 19, 2022